Your shopping cart is currently empty

Tetrahydrodeoxycorticosterone(Tetrahydro-11-deoxycorticosterone) is a potent GABAA receptor orthosteric modulator (PAM) with neuroprotective activity that selectively inhibits neurosteroid-mediated enhancement of GABA-induced currents at the GABAA receptor, and can be used in the study of neurological disorders.


| Description | Tetrahydrodeoxycorticosterone(Tetrahydro-11-deoxycorticosterone) is a potent GABAA receptor orthosteric modulator (PAM) with neuroprotective activity that selectively inhibits neurosteroid-mediated enhancement of GABA-induced currents at the GABAA receptor, and can be used in the study of neurological disorders. |
| In vitro | At physiological concentrations, the endogenous neurosteroid Tetrahydrodeoxycorticosterone (THDOC) selectively enhances tonic currents mediated by αβδ receptors[1]. In the hippocampus, the reduction of neuronal excitability is observed with 10 nM Tetrahydrodeoxycorticosterone, achieved by augmenting tonic αβδ receptor currents. Notably, in thalamocortical neurons, although 100 nM Tetrahydrodeoxycorticosterone enhances tonic currents, the same effect is not observed with 10 nM Tetrahydrodeoxycorticosterone[1]. |
| In vivo | Sufficient concentrations of Tetrahydrodeoxycorticosterone (THDOC) in the brain tissue of mice with hepatic encephalopathy (HE), arising from toxic liver injury, can induce sedation in animals of the same species[2]. |
| Synonyms | Tetrahydro-11-deoxycorticosterone, 21-Hydroxypregnanolone |
| Molecular Weight | 334.49 |
| Formula | C21H34O3 |
| Cas No. | 567-03-3 |
| Smiles | [H][C@@]12CC[C@H](C(=O)CO)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@]2([H])C[C@H](O)CC[C@]12C |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 90 mg/mL (269.07 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.